Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score
Authors' conclusion
Both parJADAS and patJADAS were found to possess good measurement properties and to serve as a surrogate of physicians' evaluations.
Study context
- Population
- Patients with juvenile idiopathic arthritis (JIA) in two large multinational datasets
- Comparison
- parJADAS vs patJADAS
- Outcome
- Measurement properties of parJADAS and patJADAS
Methodological detailsmultinational datasets
- Multinational datasets
Performance
As reported in the abstract
Internal consistency, Cronbach's α
> 0.80
Responsiveness to clinically important change (fair), standardized response mean
0.71
Original publication
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score. Rheumatology (Oxford). Published 4 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →